Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Group S.a. Artal

Director at Lexicon Pharmaceuticals, Inc. (LXRX)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return+29.9%
vs. S&P 500+24.2%
Beat the market100%
Paper profit on buys+$585K
Total bought / sold$2.0M / $0

Reported trades

Filed Stock Type Shares Price Value Since
Feb 4SEC LXRXLexicon Pharmaceuticals, Inc. Buy 1,538,462new position $1.30 $2.0M +29.2%
  • Buy

    Director Group S.a. Artal bought $2.0M of LXRX at $1.30 — first open-market purchase in our records; opens a new position.